Literature DB >> 30821201

Dynamically borrowing strength from another study through shrinkage estimation.

Christian Röver1, Tim Friede1.   

Abstract

Meta-analytic methods may be used to combine evidence from different sources of information. Quite commonly, the normal-normal hierarchical model (NNHM) including a random-effect to account for between-study heterogeneity is utilized for such analyses. The same modeling framework may also be used to not only derive a combined estimate, but also to borrow strength for a particular study from another by deriving a shrinkage estimate. For instance, a small-scale randomized controlled trial could be supported by a non-randomized study, e.g. a clinical registry. This would be particularly attractive in the context of rare diseases. We demonstrate that a meta-analysis still makes sense in this extreme case, effectively based on a synthesis of only two studies, as illustrated using a recent trial and a clinical registry in Creutzfeld-Jakob disease. Derivation of a shrinkage estimate within a Bayesian random-effects meta-analysis may substantially improve a given estimate even based on only a single additional estimate while accounting for potential effect heterogeneity between the studies. Alternatively, inference may equivalently be motivated via a model specification that does not require a common overall mean parameter but considers the treatment effect in one study, and the difference in effects between the studies. The proposed approach is quite generally applicable to combine different types of evidence originating, e.g. from meta-analyses or individual studies. An application of this more general setup is provided in immunosuppression following liver transplantation in children.

Entities:  

Keywords:  Bayesian statistics; Random-effects meta-analysis; between-study heterogeneity; posterior predictive p-values; shrinkage estimation

Mesh:

Year:  2019        PMID: 30821201     DOI: 10.1177/0962280219833079

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  4 in total

1.  An adaptive power prior for sequential clinical trials - Application to bridging studies.

Authors:  Adrien Ollier; Satoshi Morita; Moreno Ursino; Sarah Zohar
Journal:  Stat Methods Med Res       Date:  2019-11-15       Impact factor: 3.021

2.  Estimating Similarity of Dose-Response Relationships in Phase I Clinical Trials-Case Study in Bridging Data Package.

Authors:  Adrien Ollier; Sarah Zohar; Satoshi Morita; Moreno Ursino
Journal:  Int J Environ Res Public Health       Date:  2021-02-09       Impact factor: 3.390

3.  Sensitivity and identification quantification by a relative latent model complexity perturbation in Bayesian meta-analysis.

Authors:  Małgorzata Roos; Sona Hunanyan; Haakon Bakka; Håvard Rue
Journal:  Biom J       Date:  2021-08-10       Impact factor: 1.715

4.  Data monitoring committees for clinical trials evaluating treatments of COVID-19.

Authors:  Tobias Mütze; Tim Friede
Journal:  Contemp Clin Trials       Date:  2020-09-19       Impact factor: 2.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.